This compound is a pharmaceutical intermediate used in the synthesis of lenacapavir. It is a polycyclic molecule containing multiple aromatic rings, ether linkages, and halogen substituents, with a carboxylic acid functional group.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2001608-72-4
3-methanesulfonyl-3-methylbut-1-yne
Lenacapavir intermediate
N-Desmethylsulfonyl Lenacapavir
Lenacapavir intermediate
(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoic acid
Lenacapavir intermediate
1-Pyrrolidinecarboxylic acid, 2,2'-[[(2R,5R)-1-[3,5-difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-, 1,1'-bis(1,1-dimethylethyl) ester, (2S,2'S)-
Lenacapavir intermediate
1-Benzyl 2-methyl (2S)-4-methylidenepyrrolidine-1,2-dicarboxylate
Pharmaceutical intermediate for synthesis
2-Amino-6-chloropurine riboside
pharmaceutical intermediate for nucleotide synthesis
2'-o,4'-c-methyleneuridine
pharmaceutical intermediate
4alpha,5-Epoxy-5alpha-androst-2-eno(2,3-d)isoxazol-17beta-ol
steroid heterocycle intermediate
(1R,14E,18R,22R,26S,29S)-26-tert-butyl-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxylic acid
GAWSCEHDGCHIPM-CARGABRYSA-N
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)O)OC3=NC4=CC=CC=C4N=C3C(/C=C/CO[C@@H]5CCC[C@H]5OC(=O)N1)(F)F
—